HCV Test Types and Innovations

Barriers to access to hepatitis C treatment 
H. Yilmaz, E. M. Yilmaz and H. Leblebicioglu
Journal of infection in developing countries 2016;10(4):308-16. doi: 10.3855/jidc.7849

ASSESEMENT OF THE SEVERITY OF IMMUNODEFICIENCY IN PATIENTS OF ASIAN ETHNICITY WITH HIV/HCV CO-INFECTION 
R. Begaidarova, L. Asenova, G. Alshynbekova, Kh Devdariani, A. Dyusembaeva, Y. Starikov and O. Zolotareva
Georgian medical news May 2016;(254):53-6. doi:

Molecular characterization of HCV in a Swedish county over 8 years (2002-2009) reveals distinct transmission patterns 
J. Ederth, C. Jern, H. Norder, L. Magnius, E. Alm, B. K. Rognsvag, C. G. Sundin, M. Brytting, J. Esbjornsson and M. Mild
Infection ecology & epidemiology 2016;6():30670. doi: 10.3402/iee.v6.30670

Liver fibrosis progression and clinical outcomes are intertwined: role of CD4+ T-cell count and NRTI exposure from a large cohort of HIV/HCV-coinfected patients with detectable HCV-RNA: A MASTER cohort study 
E. Foca, M. Fabbiani, M. Prosperi, E. Quiros Roldan, F. Castelli, F. Maggiolo, E. Di Filippo, S. Di Giambenedetto, R. Gagliardini, A. Saracino, M. Di Pietro, A. Gori, L. Sighinolfi, A. Pan, M. C. Postorino and C. Torti
Medicine Jul 2016;95(29):e4091. doi: 10.1097/md.0000000000004091

How much of a problem is resistance in treating hepatitis C? 
D. M. Forton
Current opinion in infectious diseases Sep 26 2016;():. doi: 10.1097/qco.0000000000000319

Liver Failure due to Acute Viral Hepatitis (A-E) 
P. Manka, J. Verheyen, G. Gerken and A. Canbay
Visceral medicine Apr 2016;32(2):80-5. doi: 10.1159/000444915

Is increased HCV case-finding combined with current or 8-12 week DAA therapy cost-effective in UK prisons? A prevention benefit analysis 
N. K. Martin, P. Vickerman, I. F. Brew, J. Williamson, A. Miners, W. L. Irving, S. Saksena, S. J. Hutchinson, S. Mandal, E. O'Moore and M. Hickman
Hepatology (Baltimore, Md.) Feb 10 2016;():. doi: 10.1002/hep.28497

Hepatitis C treatment initiation in HIV-HCV coinfected patients 
L. Cotte, P. Pugliese, M. A. Valantin, L. Cuzin, E. Billaud, C. Duvivier, A. Naqvi, A. Cheret, D. Rey, P. Pradat and I. Poizot-Martin
BMC infectious diseases 2016;16():345. doi: 10.1186/s12879-016-1681-1

Addressing barriers to the prevention, diagnosis and treatment of hepatitis B and C in the face of persisting fiscal constraints in Europe: report from a high level conference 
G. Papatheodoridis, H. C. Thomas, C. Golna, M. Bernardi, M. Carballo, M. Cornberg, G. Dalekos, B. Degertekin, S. Dourakis, R. Flisiak, D. Goldberg, C. Gore, I. Goulis, S. Hadziyannis, G. Kalamitsis, P. Kanavos, A. Kautz, I. Koskinas, B. R. Leite, M. Malliori, S. Manolakopoulos, M. Maticic, V. Papaevangelou, A. Pirona, D. Prati, M. Raptopoulou-Gigi, T. Reic, G. Robaeys, E. Schatz, K. Souliotis, Y. Tountas, S. Wiktor, D. Wilson, J. Yfantopoulos and A. Hatzakis
Journal of viral hepatitis Feb 2016;23 Suppl 1():1-12. doi: 10.1111/jvh.12493

Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis 
L. Platt, P. Easterbrook, E. Gower, B. McDonald, K. Sabin, C. McGowan, I. Yanny, H. Razavi and P. Vickerman
The Lancet. Infectious diseases Jul 2016;16(7):797-808. doi: 10.1016/s1473-3099(15)00485-5 Epub 2016 Feb 25

Hepatitis C - Assessment to Treatment Trial (HepCATT) in primary care: study protocol for a cluster randomised controlled trial 
K. Roberts, J. Macleod, C. Metcalfe, J. Simon, J. Horwood, W. Hollingworth, S. Marlowe, F. H. Gordon, P. Muir, B. Coleman, P. Vickerman, G. I. Harrison, C. A. Waldron, W. Irving and M. Hickman
Trials 2016;17():366. doi: 10.1186/s13063-016-1501-3

The cost impact of outreach testing and treatment for hepatitis C in an urban Drug Treatment Unit 
N. Selvapatt, T. Ward, L. Harrison, J. Lombardini, M. Thursz, P. McEwan and A. Brown
Liver international : official journal of the International Association for the Study of the Liver Aug 27 2016;():. doi: 10.1111/liv.13240

The epidemiological changes of HCV and HBV infections in the era of new antiviral therapies and the anti-HBV vaccine 
C. Stasi, C. Silvestri, F. Voller and F. Cipriani
Journal of infection and public health Jul-Aug 2016;9(4):389-95. doi: 10.1016/j.jiph.2015.05.004

Breaking Down Barriers to Care in Hepatitis C Virus Infection 
M. Thursz and K. Lacombe
The Journal of infectious diseases Apr 1 2016;213(7):1055-6. doi: 10.1093/infdis/jiv427

Hepatitis C in the Russian Federation: challenges and future directions 
S. Mukomolov, G. Trifonova, I. Levakova, D. Bolsun and E. Krivanogova
Hepatic medicine : evidence and research 2016;8():51-60. doi: 10.2147/hmer.s50172

Cost-Effectiveness of HBV and HCV Screening Strategies--A Systematic Review of Existing Modelling Techniques 
C. Geue, O. Wu, Y. Xin, R. Heggie, S. Hutchinson, N. K. Martin, E. Fenwick and D. Goldberg
PloS one 2015;10(12):e0145022. doi: 10.1371/journal.pone.0145022

Cost-Effectiveness of HBV and HCV Screening Strategies - A Systematic Review of Existing Modelling Techniques 
C. Geue, O. Wu, Y. Xin, R. Heggie, S. Hutchinson, N. K. Martin, E. Fenwick and D. Goldberg
PloS one 2015;10(12):e0145022. doi: 10.1371/journal.pone.0145022

Enhanced surveillance of hepatitis C in the EU, 2006 - 2012 
E. F. Duffell, M. J. van de Laar and A. J. Amato-Gauci
Journal of viral hepatitis Jul 2015;22(7):590-5. doi: 10.1111/jvh.12367 Epub 2014 Nov 25

Hepatitis C core antigen testing: a reliable, quick, and potentially cost-effective alternative to hepatitis C polymerase chain reaction in diagnosing acute hepatitis C virus infection 
F. V. Cresswell, M. Fisher, D. J. Hughes, S. G. Shaw, G. Homer and M. O. Hassan-Ibrahim
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America Jan 15 2015;60(2):263-6. doi: 10.1093/cid/ciu782

Economic evaluation of screening programs for hepatitis C virus infection: evidence from literature 
S. Coretti, F. Romano, V. Orlando, P. Codella, S. Prete, E. Di Brino and M. Ruggeri
Risk management and healthcare policy 2015;8():45-54. doi: 10.2147/rmhp.s56911

Hepatitis C seroconversions in HIV infection across Europe: which regions and patient groups are affected? 
C. Boesecke, D. Grint, V. Soriano, J. D. Lundgren, A. d'Arminio Monforte, V. M. Mitsura, N. Chentsova, V. Hadziosmanovic, O. Kirk, A. Mocroft, L. Peters and J. K. Rockstroh
Liver international : official journal of the International Association for the Study of the Liver Nov 2015;35(11):2384-91. doi: 10.1111/liv.12848 Epub 2015 Apr 29

The undiagnosed chronically-infected HCV population in France. Implications for expanded testing recommendations in 2014 
C. Brouard, Y. Le Strat, C. Larsen, M. Jauffret-Roustide, F. Lot and J. Pillonel
PloS one 2015;10(5):e0126920. doi: 10.1371/journal.pone.0126920

Targeted hepatitis C antibody testing interventions: a systematic review and meta-analysis 
E. J. Aspinall, J. S. Doyle, S. Corson, M. E. Hellard, D. Hunt, D. Goldberg, T. Nguyen, Y. Falck-Ytter, R. L. Morgan, B. Smith, M. Stoove, S. Z. Wiktor and S. Hutchinson
European journal of epidemiology Feb 2015;30(2):115-29. doi: 10.1007/s10654-014-9958-4 Epub 2014 Nov 11

Determinant Factors of the Direct Medical Costs Associated with Genotype 1 Hepatitis C Infection in Treatment-Experienced Patients 
E. I. Akpo, U. Sbarigia, G. Wan and J. Kleintjens
Drugs in R&D Dec 2015;15(4):335-49. doi: 10.1007/s40268-015-0109-5

The Spectrum of Malignancies among Adult HIV Cohort in Poland between 1995 and 2012: A Retrospective Analysis of 288 Cases 
J. Kowalski, G. Cholewinska, K. Pyziak-Kowalska, E. Jablonowska, G. Baralkiewicz, A. Grzeszczuk, M. Leszczyszyn-Pynka, A. Olczak, M. Jankowska, T. Mikula, M. Bociaga-Jasik, E. Firlag-Burkacka and A. Horban
Contemporary oncology (Poznan, Poland) 2015;19(3):226-35. doi: 10.5114/wo.2015.52658

The effect of introducing point-of-care or dried blood spot analysis on the uptake of hepatitis C virus testing in high-risk populations: A systematic review of the literature 
J. T. Coats and J. F. Dillon
The International journal on drug policy Nov 2015;26(11):1050-5. doi: 10.1016/j.drugpo.2015.05.001

[Chronic disease and treatment burden for patients: the example of hepatitis C] 
D. Lhuilier, F. Brugeilles and D. Rolland
Sante publique (Vandoeuvre-les-Nancy, France) Jan-Feb 2015;27(1 Suppl):S17-21. doi:

Hepatitis C in Poland in 2013 
N. Parda, M. Rosinska and M. Stepien
Przeglad epidemiologiczny 2015;69(2):257-61, 375-8. doi:

Screening and treatment for hepatitis C: a balanced perspective 
P. C. Matthews, K. Jeffery, P. Klenerman, E. Barnes and G. Cooke
BMJ (Clinical research ed.) 2015;350():h644. doi: 10.1136/bmj.h644

Where next for hepatitis B and C surveillance? 
S. Z. Wiktor
Journal of viral hepatitis Jul 2015;22(7):571-3. doi: 10.1111/jvh.12400

Hepatitis C: a changing epidemic 
G. Wandeler, J. F. Dufour, P. Bruggmann and A. Rauch
Swiss medical weekly 2015;145():w14093. doi: 10.4414/smw.2015.14093

[Financial burden of hepatitis C infection and its treatment] 
M. Makara and B. Hunyady
Orvosi hetilap May 24 2015;156(21):862-8. doi: 10.1556/650.2015.30182

Supporting general practices to provide sexual and reproductive health services: protocol for the 3Cs & HIV programme 
K. Town, E. J. Ricketts, T. Hartney, J. K. Dunbar, A. Nardone, K. A. Folkard, A. Charlett and C. A. McNulty
Public health Sep 2015;129(9):1244-50. doi: 10.1016/j.puhe.2015.07.016 Epub 2015 Aug 13

[Hepatitis C in Germany: an analysis of statutory sickness funds claims data] 
J. Tomeczkowski and M. Cornberg
Deutsche medizinische Wochenschrift (1946) Apr 2015;140(8):e67-73. doi: 10.1055/s-0041-101101 Epub 2015 Apr 16

Epidemiology of hepatitis C in Croatia in the European context 
T. Vilibic-Cavlek, J. Kucinar, B. Kaic, M. Vilibic, N. Pandak, L. Barbic, V. Stevanovic and J. Vranes
World journal of gastroenterology Aug 28 2015;21(32):9476-93. doi: 10.3748/wjg.v21.i32.9476

Routine testing for blood-borne viruses in prisons: a systematic review 
C. Rumble, D. J. Pevalin and E. O'Moore
European journal of public health Dec 2015;25(6):1078-88. doi: 10.1093/eurpub/ckv133 Epub 2015 Jul 27

Chronic hepatitis C: treat everyone now or stratify by disease? 
T. Reiberger
Minerva gastroenterologica e dietologica Mar 2015;61(1):11-9. doi: Epub 2014 Oct 30

Estimating the treatment cascade of chronic hepatitis B and C in Greece using a telephone survey 
G. Papatheodoridis, V. Sypsa, M. Kantzanou, I. Nikolakopoulos and A. Hatzakis
Journal of viral hepatitis Apr 2015;22(4):409-15. doi: 10.1111/jvh.12314 Epub 2014 Sep 11

[Hepatitis C: in 2015, who should be screened first?] 
J. Y. Nau
Revue medicale suisse Apr 15 2015;11(470):888-9. doi:

Early diagnosis and treatment: the goal of hepatitis C screening 
N. Selvapatt, A. Brown and M. Thursz
BMJ (Clinical research ed.) 2015;350():h635. doi: 10.1136/bmj.h635

Rise in testing and diagnosis associated with Scotland's Action Plan on Hepatitis C and introduction of dried blood spot testing 
A. McLeod, A. Weir, C. Aitken, R. Gunson, K. Templeton, P. Molyneaux, P. McIntyre, S. McDonald, D. Goldberg and S. Hutchinson
Journal of epidemiology and community health Dec 2014;68(12):1182-8. doi: 10.1136/jech-2014-204451 Epub 2014 Aug 28

Towards hepatitis C eradication from the HIV-infected population 
P. Barreiro, J. V. Fernandez-Montero, C. de Mendoza, P. Labarga and V. Soriano
Antiviral research May 2014;105():1-7. doi: 10.1016/j.antiviral.2014.02.004 Epub 2014 Feb 15

Hepatitis C among people who inject drugs in Tbilisi, Georgia: an urgent need for prevention and treatment 
J. Bouscaillou, J. Champagnat, N. Luhmann, E. Avril, I. Inaridze, V. Miollany, K. Labartkava, I. Kirtadze, M. Butsashvili, G. Kamkamidze and D. Pataut
The International journal on drug policy Sep 2014;25(5):871-8. doi: 10.1016/j.drugpo.2014.01.007 Epub 2014 Jan 23

Improve screening of HCV infection by targeting high prevalence aged groups: analysis of a cohort of HCV and HIV co-infected patients 
P. Brogueira, A. Costa, A. Miranda, S. Peres, T. Baptista, I. Aldir, I. Antunes, F. Ventura, F. Borges and K. Mansinho
Journal of the International AIDS Society 2014;17(4 Suppl 3):19601. doi: 10.7448/ias.17.4.19601

[The diagnosis of hepatitis C virus infection] 
J. Gervain
Orvosi hetilap Jun 29 2014;155(26):1019-23. doi: 10.1556/oh.2014.29972

Hepatitis C, from screening to treatment, a revolution 
K. Lacombe
Journal of the International AIDS Society 2014;17(4 Suppl 3):19499. doi: 10.7448/ias.17.4.19499

Seroprevalence of HCV and HIV infections by year of birth in Spain: impact of US CDC and USPSTF recommendations for HCV and HIV testing 
A. Mena, L. Moldes, H. Meijide, A. Canizares, A. Castro-Iglesias, M. Delgado, S. Pertega, J. Pedreira, G. Bou and E. Poveda
PloS one 2014;9(12):e113062. doi: 10.1371/journal.pone.0113062

Screening tests for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus in blood donors: evaluation of two chemiluminescent immunoassay systems 
L. Sommese, C. Sabia, R. Paolillo, D. Parente, M. Capuano, C. Iannone, F. Cavalca, C. Schiano, M. Vasco, M. R. De Pascale, A. Casamassimi and C. Napoli
Scandinavian journal of infectious diseases Sep 2014;46(9):660-4. doi: 10.3109/00365548.2014.926564 Epub 2014 Jul 30

New hepatitis C therapies: the toolbox, strategies, and challenges 
J. M. Pawlotsky
Gastroenterology May 2014;146(5):1176-92. doi: 10.1053/j.gastro.2014.03.003 Epub 2014 Mar 12

Distribution pattern of hepatitis C virus genotypes and correlation with viral load and risk factors in chronic positive patients 
A. Petruzziello, N. Coppola, G. Loquercio, S. Marigliano, M. Giordano, R. Azzaro, A. M. Diodato, V. Iervolino, G. Di Costanzo, C. A. Di Macchia, T. Di Meo, L. Paradiso, R. Ferro, P. Giuliano, F. Russo, G. Pasquale and C. Cacciapuoti
Intervirology 2014;57(6):311-8. doi: 10.1159/000363386 Epub 2014 Aug 22

Complexities of HCV management in the new era of direct-acting antiviral agents 
W. M. Rosenberg, S. Tanwar and P. Trembling
QJM : monthly journal of the Association of Physicians Jan 2014;107(1):17-9. doi: 10.1093/qjmed/hct181 Epub 2013 Sep 23

Point-of-care testing for HCV infection: recent advances and implications for alternative screening 
M. R. Parisi, L. Soldini, G. Vidoni, C. Mabellini, T. Belloni, L. Brignolo, S. Negri, K. Schlusnus, F. Dorigatti and A. Lazzarin
The new microbiologica Oct 2014;37(4):449-57. doi:

HCV transmission in industrialized countries and resource-constrained areas 
M. Thursz and A. Fontanet
Nature reviews. Gastroenterology & hepatology Jan 2014;11(1):28-35. doi: 10.1038/nrgastro.2013.179

[Treatment of hepatitis C: what is known?] 
H. Wedemeyer
Der Internist Dec 2014;55(12):1419-26. doi: 10.1007/s00108-014-3554-2

[Features of the humoral immune response in patients with chronic hepatitis C, spontaneous clearance of hepatitis C virus and false-positive reactions of anti-HCV] 
N. A. Zhandarova
Georgian medical news Jun 2014;(231):38-41. doi:

Hepatitis B virus and hepatitis C virus infections in Belgium: similarities and differences in epidemics and initial management 
B. De Vroey, C. Moreno, W. Laleman, M. van Gossum, I. Colle, C. de Galocsy, P. Langlet, G. Robaeys, H. Orlent, P. Michielsen, J. Delwaide, H. Reynaert, F. D'Heygere, D. Sprengers, S. Bourgeois, C. Assene, B. Vos, R. Brenard, M. Adler, J. Henrion and P. Deltenre
European journal of gastroenterology & hepatology May 2013;25(5):613-9. doi: 10.1097/MEG.0b013e32835d83a2

Hepatitis C virus therapy is associated with lower health care costs not only in noncirrhotic patients but also in patients with end-stage liver disease 
S. C. Gordon, F. M. Hamzeh, P. J. Pockros, R. S. Hoop, A. R. Buikema, E. J. Korner and N. A. Terrault
Alimentary pharmacology & therapeutics Oct 2013;38(7):784-93. doi: 10.1111/apt.12454 Epub 2013 Aug 25

Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening 
S. J. Hahne, I. K. Veldhuijzen, L. Wiessing, T. A. Lim, M. Salminen and Mv Laar
BMC infectious diseases 2013;13():181. doi: 10.1186/1471-2334-13-181

[Epidemiology of viral hepatitis] 
B. Kaic, T. Vilibic-Cavlek, S. K. Filipovic, T. Nemeth-Blazic, I. Pem-Novosel, V. V. Vucina, A. Simunovic, M. Zajec, I. Radic, J. Pavlic, M. Glamocanin and I. Gjenero-Margan
Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti Oct 2013;67(4):273-9. doi:

Evaluation of a rapid on-site anti-HCV test as a screening tool for hepatitis C virus infection 
J. Kant, B. Moller, R. Heyne, A. Herber, S. Bohm, M. Maier, U. G. Liebert, J. Mossner, T. Berg and J. Wiegand
European journal of gastroenterology & hepatology Apr 2013;25(4):416-20. doi: 10.1097/MEG.0b013e32835c502d

Treatment optimization and prediction of HCV clearance in patients with acute HCV infection 
A. Mangia, R. Santoro, M. Copetti, M. Massari, V. Piazzolla, E. Spada, G. Cappucci, G. Missale, L. Mottola, E. Agostinacchio, Ld Mauro, O. Zuccaro, P. Maio, F. Pellegrini, A. Folgori and C. Ferrari
Journal of hepatology Aug 2013;59(2):221-8. doi: 10.1016/j.jhep.2013.04.007 Epub 2013 Apr 12

Directly acting antivirals for the treatment of chronic hepatitis C: unresolved topics from registration trials 
A. Aghemo, E. Degasperi and M. Colombo
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver Jan 2013;45(1):1-7. doi: 10.1016/j.dld.2012.05.002 Epub 2012 Jun 12

Raising public awareness of hepatitis B and C through a testing road show 
S. Perrett and P. Hams
British journal of nursing (Mark Allen Publishing) Dec 12-2014 Jan 8 2013;22(22):1308, 1310-2. doi: 10.12968/bjon.2013.22.22.1308

Hepatitis C: the case against routine partner notification 
R. Poll
International journal of STD & AIDS Mar 2013;24(3):165-8. doi: 10.1177/0956462412472311

Hepatitis C in Poland in 2011 
M. Rosinska, N. Parda and M. Stepien
Przeglad epidemiologiczny 2013;67(2):247-51, 353-6. doi:

How did chronic hepatitis C impact costs related to hospital health care in France in 2009? 
M. Rotily, A. Vainchtock, B. Jouaneton, C. Wartelle-Bladou and A. Abergel
Clinics and research in hepatology and gastroenterology Sep 2013;37(4):365-72. doi: 10.1016/j.clinre.2012.11.004 Epub 2012 Dec 27

Economic assessment of an anti-HCV screening program in Italy 
M. Ruggeri, S. Coretti, A. Gasbarrini and A. Cicchetti
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research Sep-Oct 2013;16(6):965-72. doi: 10.1016/j.jval.2013.07.005

HCV burden in Europe and the possible impact of current treatment 
P. Mathurin
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver Sep 30 2013;45 Suppl 5():S314-7. doi: 10.1016/j.dld.2013.07.009

Acute hepatitis C in patients with HIV 
C. Boesecke and J. K. Rockstroh
Seminars in liver disease May 2012;32(2):130-7. doi: 10.1055/s-0032-1316468

Cost-effectiveness of additional blood screening tests in the Netherlands 
B. A. Borkent-Raven, M. P. Janssen, C. L. van der Poel, G. J. Bonsel and B. A. van Hout
Transfusion Mar 2012;52(3):478-88. doi: 10.1111/j.1537-2995.2011.03319.x Epub 2011 Aug 31

HCV seroconversion among never-injecting heroin users at baseline: no predictors identified other than starting injection 
M. J. Bravo, F. Vallejo, G. Barrio, M. T. Brugal, G. Molist, J. Pulido, L. Sordo and L. de la Fuente
The International journal on drug policy Sep 2012;23(5):415-9. doi: 10.1016/j.drugpo.2012.02.002 Epub 2012 Mar 14

Treatment for hepatitis B virus (HBV) and hepatitis C virus (HCV) infection - Danish national guidelines 2011 
P. B. Christensen, M. R. Clausen, H. Krarup, A. L. Laursen, P. Schlichting and N. Weis
Danish medical journal Jun 2012;59(6):C4465. doi:

Hepatitis C prevalence in Denmark -an estimate based on multiple national registers 
P. B. Christensen, G. Hay, P. Jepsen, L. H. Omland, S. A. Just, H. B. Krarup, N. Weis, N. Obel and S. Cowan
BMC infectious diseases 2012;12():178. doi: 10.1186/1471-2334-12-178

Impact of hepatitis C triple therapy availability upon the number of patients to be treated and associated costs in France: a model-based analysis 
S. Deuffic-Burban, P. Mathurin, S. Pol, C. Larsen, F. Roudot-Thoraval, J. C. Desenclos, D. Dhumeaux and Y. Yazdanpanah
Gut Feb 2012;61(2):290-6. doi: 10.1136/gutjnl-2011-300586 Epub 2011 Sep 19

Improving targeted screening for hepatitis C in the UK 
C. J. Duncan, E. Stewart and R. Fox
BMJ (Clinical research ed.) 2012;345():e6525. doi: 10.1136/bmj.e6525

Economic burden of hepatitis C-associated diseases: Europe, Asia Pacific, and the Americas 
A. C. El Khoury, C. Wallace, W. K. Klimack and H. Razavi
Journal of medical economics 2012;15(5):887-96. doi: 10.3111/13696998.2012.681332 Epub 2012 May 24

[Demographic profile of a person with symptomatic hepatitis C in Poland] 
M. Kajko, J. Slusarczyk, M. Czarkowski and M. Rosinska
Przeglad epidemiologiczny 2012;66(2):351-6. doi:

Anti-HCV prevalence in the general population of Lithuania 
V. Liakina and J. Valantinas
Medical science monitor : international medical journal of experimental and clinical research Mar 2012;18(3):Ph28-35. doi:

Public health issues of hepatitis C virus infection 
G. Papatheodoridis and A. Hatzakis
Best practice & research. Clinical gastroenterology Aug 2012;26(4):371-80. doi: 10.1016/j.bpg.2012.09.012

Hepatitis C: epidemiology, diagnosis, natural history and therapy 
S. Pol, A. Vallet-Pichard, M. Corouge and V. O. Mallet
Contributions to nephrology 2012;176():1-9. doi: 10.1159/000332374 Epub 2012 Jan 30

[Hepatitis C in Poland in 2010] 
M. Rosinska, F. Radziszewski and M. Stepien
Przeglad epidemiologiczny 2012;66(2):287-92. doi:

The more you look, the more you find: effects of hepatitis C virus testing interval on reinfection incidence and clearance and implications for future vaccine study design 
P. Vickerman, J. Grebely, G. J. Dore, R. Sacks-Davis, K. Page, D. L. Thomas, W. O. Osburn, A. L. Cox, C. K. Aitken, M. Hickman and M. Hellard
The Journal of infectious diseases May 1 2012;205(9):1342-50. doi: 10.1093/infdis/jis213 Epub 2012 Mar 29

Hepatitis C virus infections in the Swiss HIV Cohort Study: a rapidly evolving epidemic 
G. Wandeler, T. Gsponer, A. Bregenzer, H. F. Gunthard, O. Clerc, A. Calmy, M. Stockle, E. Bernasconi, H. Furrer and A. Rauch
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America Nov 15 2012;55(10):1408-16. doi: 10.1093/cid/cis694 Epub 2012 Aug 14

Cost-effectiveness of targeted screening for hepatitis C in The Netherlands 
C. W. Helsper, B. A. Borkent-Raven, N. J. de Wit, G. A. van Essen, M. J. Bonten, A. I. Hoepelman, M. P. Janssen and G. A. de Wit
Epidemiology and infection Jan 2012;140(1):58-69. doi: 10.1017/s0950268811000112 Epub 2011 Feb 16

HIV and hepatitis C co-infection: acute HCV therapy 
C. Boesecke and M. Vogel
Current opinion in HIV and AIDS Nov 2011;6(6):459-64. doi: 10.1097/COH.0b013e32834b87de

[Serology of viral hepatitis] 
V. Gisler, E. Battegay and B. Mullhaupt
Praxis Nov 2 2011;100(22):1323-34; quiz 1333. doi: 10.1024/1661-8157/a000709

Prevalence and risk factors of HCV infection in Poland 
R. Flisiak, W. Halota, A. Horban, J. Juszczyk, M. Pawlowska and K. Simon
European journal of gastroenterology & hepatology Nov 2011;23(12):1213-7. doi: 10.1097/MEG.0b013e32834d173c

Minimal transmission of HIV despite persistently high transmission of hepatitis C virus in a Swedish needle exchange program 
M. A. Blome, P. Bjorkman, L. Flamholc, H. Jacobsson, V. Molnegren and A. Widell
Journal of viral hepatitis Dec 2011;18(12):831-9. doi: 10.1111/j.1365-2893.2010.01400.x Epub 2010 Nov 29